EP3180363
SIRP-ALFA ónæmisglóbúlín samrunaprótín
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.8.2015EP published:
25.9.2019EP application number:
15750744.3
EP translation filed:
25.10.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
13.8.2035Expiry date:
13.8.2022
Title:
SIRP-ALPHA IMMUNOGLOBULIN FUSION PROTEINS
Timeline
Today
14.8.2015EP application
25.9.2019EP Publication
25.10.2019Translation submitted
15.11.2019Registration published
13.8.2022Expires
Owner
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293, Darmstadt, DE
Inventor
Name:
LO, Kin-MingAddress:
Lexington, Massachusetts, US
Name:
ZIZLSPERGER, NoraAddress:
Newton, Massachusetts, US
Name:
SIRCAR, AroopAddress:
Billerica,MA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201462038196 PDate:
15.8.2014Country:
US
Classification
Categories:
C07K 16/46, C07K 14/705, A61K 38/00, C07K 16/28, C07K 16/30, C07K 16/32, C12N 9/16
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 8.7.2020
Expires: 13.8.2021
Payer: Árnason Faktor ehf.
Number: 7
Paid: 12.7.2021
Expires: 13.8.2022
Payer: Árnason Faktor ehf.